Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbohydrate sulfotransferase 6 is a Golgi-localized enzyme encoded by the CHST6 gene. It catalyzes the transfer of a sulfate group to the 6-position of N-acetylglucosamine (GlcNAc) residues in keratan, a glycosaminoglycan critical for the maintenance of corneal transparency. Defects or mutations in CHST6 result in abnormal sulfation patterns in keratan sulfate, leading to macular corneal dystrophy, characterized by progressive vision loss due to corneal clouding. The enzyme primarily acts in keratan sulfate biosynthesis, working with other glycosyltransferases and sulfotransferases to construct the extracellular matrix of the cornea[1][2][3][6].
Drugs targeting CHST6 (теоретически) would act as enzyme inhibitors or modulating substrate availability, potentially altering keratan sulfate biosynthesis. No specific drugs currently in clinical use or noted in major databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbohydrate sulfotransferase 6 (CHST6).